BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16151337)

  • 1. Serial audiometry in a clinical trial of AIED treatment.
    Niparko JK; Wang NY; Rauch SD; Russell GB; Espeland MA; Pierce JJ; Bowditch S; Masuda A; Gulya AJ; Gantz BJ; Hughes GB; Brookhouser PE; Hannley MT; Telian SA; Harris JP;
    Otol Neurotol; 2005 Sep; 26(5):908-17. PubMed ID: 16151337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune inner ear disease preliminary case report: audiometric findings following steroid treatments.
    Harris DA; Mikulec AA; Carls SL
    Am J Audiol; 2013 Jun; 22(1):120-4. PubMed ID: 23800807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in autoimmune inner ear disease treatment and audiological outcomes.
    Maxwell PJ; Ranjbar PA; Winkler D; Kuzy J; McGovern B; Sataloff RT
    Am J Otolaryngol; 2023; 44(4):103875. PubMed ID: 37058909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otitis media with effusion in children: Cross-frequency correlation in pure tone audiometry.
    Chow AHC; Cai T; McPherson B; Yang F
    PLoS One; 2019; 14(8):e0221405. PubMed ID: 31437206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorineural Hearing Loss and Systemic Autoimmune Disease: The Experience of a Systemic Immune-Mediated Diseases Unit.
    Ribeiro R; Serôdio JF; Amaral MC; Duarte JA; Durão C; Mendes N; Delgado Alves J
    Cureus; 2021 Mar; 13(3):e14075. PubMed ID: 33903837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
    Cohen S; Shoup A; Weisman MH; Harris J
    Otol Neurotol; 2005 Sep; 26(5):903-7. PubMed ID: 16151336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the degree of hearing loss using click auditory brainstem response in babies referred from newborn hearing screening.
    Baldwin M; Watkin P
    Ear Hear; 2013; 34(3):361-9. PubMed ID: 23340456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our auditory results using the Vibrant Soundbridge on the long process of the incus: 20 years of data.
    Grégoire A; Van Damme JP; Gilain C; Bihin B; Garin P
    Auris Nasus Larynx; 2018 Feb; 45(1):66-72. PubMed ID: 28285827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a combination of click- and tone burst-evoked auditory brain stem response measurements to estimate pure-tone thresholds.
    Gorga MP; Johnson TA; Kaminski JR; Beauchaine KL; Garner CA; Neely ST
    Ear Hear; 2006 Feb; 27(1):60-74. PubMed ID: 16446565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of conductive hearing loss using air conduction tests alone: reliability and validity of an automatic test battery.
    Convery E; Keidser G; Seeto M; Freeston K; Zhou D; Dillon H
    Ear Hear; 2014; 35(1):e1-8. PubMed ID: 24080948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease.
    Derebery MJ; Fisher LM; Voelker CC; Calzada A
    Otol Neurotol; 2014 Oct; 35(9):1515-21. PubMed ID: 25203561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease.
    Vambutas A; Lesser M; Mullooly V; Pathak S; Zahtz G; Rosen L; Goldofsky E
    J Clin Invest; 2014 Sep; 124(9):4115-22. PubMed ID: 25133431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure-tone and speech audiometry in patients with Menière's disease.
    Mateijsen DJ; Van Hengel PW; Van Huffelen WM; Wit HP; Albers FW
    Clin Otolaryngol Allied Sci; 2001 Oct; 26(5):379-87. PubMed ID: 11678945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of multi-channel auditory steady-state response in adults with sensorineural hearing loss.
    Lin YH; Chen PR; Hsu CJ; Wu HP
    J Laryngol Otol; 2009 Jan; 123(1):38-44. PubMed ID: 18452631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood psychogenic hearing loss: Identification and diagnosis.
    Parodi M; Rouillon I; Rebours C; Denoyelle F; Loundon N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Dec; 134(6):415-418. PubMed ID: 28479298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
    Dinces EA; Yang S; Balogun AO
    Laryngoscope; 2001 Jan; 111(1):21-5. PubMed ID: 11192894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hearing tests in practice : Audiometric masking in pure-tone and speech audiometry].
    Rader T; Canis M
    HNO; 2022 Oct; 70(10):783-789. PubMed ID: 36083470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.